Patents by Inventor Xuefeng Zhu

Xuefeng Zhu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11999730
    Abstract: Provided herein are inhibitors of AKT1, pharmaceutical compositions comprising the inhibitory compounds, and methods for using the AKT1 inhibitory compounds for the treatment of disease.
    Type: Grant
    Filed: September 26, 2023
    Date of Patent: June 4, 2024
    Assignee: ALTEROME THERAPEUTICS, INC.
    Inventors: Michael David Bartberger, Elena V. Dneprovskaia, Yi Fan, Eric Anthony Murphy, Xuefeng Zhu
  • Publication number: 20240174667
    Abstract: Provided herein are inhibitors of AKT1, pharmaceutical compositions comprising the inhibitory compounds, and methods for using the AKT1 inhibitory compounds for the treatment of disease.
    Type: Application
    Filed: September 26, 2023
    Publication date: May 30, 2024
    Inventors: Michael David BARTBERGER, Elena V. DNEPROVSKAIA, Yi FAN, Eric Anthony MURPHY, Xuefeng ZHU
  • Publication number: 20240166604
    Abstract: The present invention relates to the technical field of medicines, and in particular to a hydroxytyrosol nicotinamide eutectic crystal, a preparation method therefor and a composition thereof. In the hydroxytyrosol nicotinamide eutectic crystal of the present invention, a molar ratio of hydroxytyrosol to nicotinamide is 1:1, and cell parameters are as follows: a=9.4999, b=11.8285, c=11.4439, ?=90°, ?=96.628°, and ?=90°. The hydroxytyrosol nicotinamide eutectic crystal of the present invention is high in melting point, does not absorb moisture and is good in stability, and the application convenience of the hydroxytyrosol is greatly improved. The composition directly prepared by means of a grinding method has the advantages of high yield and low cost, and is suitable for large-scale application.
    Type: Application
    Filed: March 3, 2022
    Publication date: May 23, 2024
    Inventors: Xuefeng MEI, Yuhang JIANG, Bingqing ZHU
  • Patent number: 11849755
    Abstract: A stem screening and conditioning device includes a roller, a thermal insulation cover, a spiral feeding device, a compressed-air cleaning device, a steam tube, a discharge hole, and a waste hole. A stem screening and conditioning method for the stem screening and conditioning device is also provided. The present disclosure realizes the complete separation of normal-size and undersized stems under the premise of full moisture absorption, thereby improving the refinement and homogenization level of stem conditioning.
    Type: Grant
    Filed: June 6, 2022
    Date of Patent: December 26, 2023
    Assignee: CHINA TOBACCO YUNNAN INDUSTRIAL CO., LTD
    Inventors: Ze Liu, Zeyu Wang, Yuanzhen Zhou, Xuefeng Zhu, Tiansheng Dai
  • Publication number: 20230322711
    Abstract: The present invention relates to macrocyclic compounds of any one of Formula (I), or a pharmaceutically acceptable form thereof, pharmaceutical compositions comprising the same, methods of preparing the same, and methods of treating cancer dependent on a farnesylated protein, using the same.
    Type: Application
    Filed: June 5, 2023
    Publication date: October 12, 2023
    Inventors: Xuefeng Zhu, Pingda Ren, Zhu Bai, Wanting Xiong, Dan Xu, Yahu Arthur Liu
  • Publication number: 20230189868
    Abstract: A stem screening and conditioning device includes a roller, a thermal insulation cover, a spiral feeding device, a compressed-air cleaning device, a steam tube, a discharge hole, and a waste hole. A stem screening and conditioning method for the stem screening and conditioning device is also provided. The present disclosure realizes the complete separation of normal-size and undersized stems under the premise of full moisture absorption, thereby improving the refinement and homogenization level of stem conditioning.
    Type: Application
    Filed: June 6, 2022
    Publication date: June 22, 2023
    Applicant: CHINA TOBACCO YUNNAN INDUSTRIAL CO., LTD
    Inventors: Ze LIU, Zeyu WANG, Yuanzhen ZHOU, Xuefeng ZHU, Tiansheng DAI
  • Patent number: 11573413
    Abstract: An equatorial mount for providing a telescope with a balanced weight distribution is described. The equatorial mount includes a base, a declination base, and a device support. The declination base is rotatable about a right ascension axis relative to the base. The device support is rotatable about a declination axis relative to the declination base. The declination axis intersects orthogonally with the right ascension axis and the declination axis intersects a midsection of the declination base. The declination base includes a counterweight assembly extending along a counterweight axis, the counterweight axis being spaced away from the declination axis along the right ascension axis.
    Type: Grant
    Filed: January 31, 2020
    Date of Patent: February 7, 2023
    Assignee: Nantong Schmidt Opto-Electrical Technology Co., Ltd.
    Inventors: Yufeng Sun, Wenzhong Shen, Xuefeng Zhu
  • Publication number: 20220276547
    Abstract: A mount comprises: a bracket assembly for holding an image-capture device; a drive shaft rotatably coupled to a stationary wheel for rotation of the drive shaft relative to the stationary wheel about a drive shaft axis; a support member coupled to the drive shaft to rotate about the drive shaft axis therewith, the support member extending radially away from the drive shaft axis; a rotational wheel rotatably coupled to the support member for rotation of the rotational wheel relative to the support member about a rotational wheel axis radially spaced apart from, and parallel to, the drive shaft axis, and coupleable to the bracket assembly such that rotation of the rotational wheel about the rotational wheel axis causes corresponding rotation of the bracket assembly about the rotational wheel axis; and a belt entrained around the stationary wheel and the rotational wheel.
    Type: Application
    Filed: May 17, 2022
    Publication date: September 1, 2022
    Inventors: Yufeng SUN, Daming LI, Xuefeng ZHU
  • Patent number: 11320644
    Abstract: An equatorial mount having a base, a right ascension base, a right ascension shaft, a declination base, a declination shaft, and a mount-rotation mechanism, the declination base rotatable about a right ascension axis relative to the right ascension base, and the declination shaft rotatable about a declination axis relative to the declination axis, wherein the mount-rotation mechanism is engageable and disenagageable from one or the other of the right ascension shaft and the declination shaft, to apply torque between the declination base and that shaft when engaged and to permit relative rotation of the shaft and the declination base when disengaged.
    Type: Grant
    Filed: January 31, 2020
    Date of Patent: May 3, 2022
    Assignee: Nantong Schmidt Opto-Electrical Technology Co., Ltd.
    Inventors: Yufeng Sun, Wenzhong Shen, Xuefeng Zhu
  • Publication number: 20220127247
    Abstract: The invention relates to heterocyclic compounds of the formula (I) in which all of the variables are as defined in the specification; capable of modulating the activity of CFTR. The invention further provides a method for manufacturing compounds of the invention, and its therapeutic uses. The invention further provides methods to their preparation, to their medical use, in particular to their use in the treatment and management of diseases or disorders including Cystic fibrosis and related disorders.
    Type: Application
    Filed: February 4, 2020
    Publication date: April 28, 2022
    Inventors: Mihai AZIMIOARA, Bei CHEN, Robert EPPLE, James Paul LAJINESS, Casey Jacob Nelson MATHISON, Juliet NABAKKA, Victor Ivanovich NIKULIN, Sejal PATEL, Dean Paul PHILLIPS, Paul Vincent RUCKER, Andrew VALIERE, Baogen WU, Shanshan YAN, Xuefeng ZHU
  • Publication number: 20220071971
    Abstract: The invention relates to heterocyclic compounds of the formula (I), in which all of the variables are as defined in the specification; capable of modulating the activity of CFTR. The invention further provides a method for manufacturing compounds of the invention, and its therapeutic uses. The invention further provides methods to their preparation, to their medical use, in particular to their use in the treatment and management of diseases or disorders including Cystic fibrosis and related disorders.
    Type: Application
    Filed: December 18, 2019
    Publication date: March 10, 2022
    Inventors: Mihai Azimioara, Badry Bursulaya, Songchun Jiang, Casey Jacob Nelson MATHISON, Victor Ivanovich NIKULIN, Truc Ngoc NGUYEN, Barun OKRAM, Sejal PATEL, Dean Paul PHILLIPS, Lewis WHITEHEAD, Baogen WU, Shanshan YAN, Xuefeng ZHU
  • Publication number: 20210351553
    Abstract: Terminal pin device are described herein. The Terminal pin device of the invention comprises a cam box, a cutting mechanism, a material clamping mechanism, a pin inserting mechanism and a cam driving mechanism. The cutting mechanism, the material clamping mechanism, the pin inserting mechanism and the cam driving mechanism are connected with the cam box, and the cam driving mechanism drives the cutting mechanism, the material clamping mechanism and the pin inserting mechanism to operate, so as to realize the integrated terminal cutting, the terminal material clamping and the terminal rotation and terminal pin inserting actions.
    Type: Application
    Filed: February 21, 2019
    Publication date: November 11, 2021
    Inventors: Hongjian YANG, Jiadan LI, Junchen LI, Xuefeng ZHU, Fengjie ZHENG
  • Patent number: 11066369
    Abstract: The invention relates to heterocyclic compounds of the formula (I) in which all of the variables are as defined in the specification; capable of modulating the activity of CFTR. The invention further provides a method for manufacturing compounds of the invention, and its therapeutic uses. The invention further provides methods to their preparation, to their medical use, in particular to their use in the treatment and management of diseases or disorders including Cystic fibrosis and related disorders.
    Type: Grant
    Filed: September 10, 2019
    Date of Patent: July 20, 2021
    Assignee: Novartis AG
    Inventors: Mihai Azimioara, Bei Chen, Robert Epple, Ayako Honda, Philip Lam, Hasnain Ahmed Malik, Casey Jacob Nelson Mathison, True Ngoc Nguyen, Victor Ivanovich Nikulin, Sejal Patel, Dean Paul Phillips, Rodrigo A. Rodriguez, Baogen Wu, Xuefeng Zhu
  • Publication number: 20200218056
    Abstract: An equatorial mount having a base, a right ascension base, a right ascension shaft, a declination base, a declination shaft, and a mount-rotation mechanism, the declination base rotatable about a right ascension axis relative to the right ascension base, and the declination shaft rotatable about a declination axis relative to the declination axis, wherein the mount-rotation mechanism is engageable and disenagageable from one or the other of the right ascension shaft and the declination shaft, to apply torque between the declination base and that shaft when engaged and to permit relative rotation of the shaft and the declination base when disengaged.
    Type: Application
    Filed: January 31, 2020
    Publication date: July 9, 2020
    Inventors: Yufeng SUN, Wenzhong SHEN, Xuefeng ZHU
  • Publication number: 20200192076
    Abstract: An equatorial mount for providing a telescope with a balanced weight distribution is described. The equatorial mount comprises a base, a declination base, and a device support. The declination base is rotatable about a right ascension axis relative to the base. The device support is rotatable about a declination axis relative to the declination base. The declination axis intersects orthogonally with the right ascension axis and the declination axis intersects a midsection of the declination base. The declination base comprises a counterweight assembly extending along a counterweight axis, the counterweight axis being spaced away from the declination axis along the right ascension axis.
    Type: Application
    Filed: January 31, 2020
    Publication date: June 18, 2020
    Inventors: Yufeng SUN, Wenzhong SHEN, Xuefeng ZHU
  • Publication number: 20200002281
    Abstract: The invention relates to heterocyclic compounds of the formula (I) in which all of the variables are as defined in the specification; capable of modulating the activity of CFTR. The invention further provides a method for manufacturing compounds of the invention, and its therapeutic uses. The invention further provides methods to their preparation, to their medical use, in particular to their use in the treatment and management of diseases or disorders including Cystic fibrosis and related disorders.
    Type: Application
    Filed: September 10, 2019
    Publication date: January 2, 2020
    Inventors: Mihai Azimioara, Bei Chen, Robert Epple, Ayako Honda, Philip Lam, Hasnain Ahmed Malik, Casey Jacob Nelson Mathison, Truc Ngoc Nguyen, Victor Ivanovich Nikulin, Sejal Patel, Dean Paul Phillips, Rodrigo A. Rodriguez, Baogen Wu, Xuefeng Zhu
  • Patent number: 10450273
    Abstract: The invention relates to heterocyclic compounds of the formula (I) in which all of the variables are as defined in the specification; capable of modulating the activity of CFTR. The invention further provides a method for manufacturing compounds of the invention, and its therapeutic uses. The invention further provides methods to their preparation, to their medical use, in particular to their use in the treatment and management of diseases or disorders including Cystic fibrosis and related disorders.
    Type: Grant
    Filed: August 28, 2017
    Date of Patent: October 22, 2019
    Assignee: Novartis AG
    Inventors: Mihai Azimioara, Bei Chen, Robert Epple, Ayako Honda, Philip Lam, Hasnain Ahmed Malik, Casey Jacob Nelson Mathison, Truc Ngoc Nguyen, Victor Ivanovich Nikulin, Sejal Patel, Dean Paul Phillips, Rodrigo A. Rodriguez, Baogen Wu, Xuefeng Zhu
  • Patent number: 8843998
    Abstract: Embodiments of apparatus, systems and methods facilitate deployment of distributed computing applications on hybrid public-private infrastructures by facilitating secure access to selected services running on private infrastructures by distributed computing applications running on public cloud infrastructures. In some embodiments, a secure tunnel may be established between proxy processes on the public and private infrastructures and communication between the distributed computing application and the selected services may occur through the proxy processes over the secure tunnel.
    Type: Grant
    Filed: November 25, 2011
    Date of Patent: September 23, 2014
    Assignee: Cliqr Technologies, Inc.
    Inventors: Tianying Fu, Gaurav Manglik, Xuefeng Zhu
  • Patent number: D835315
    Type: Grant
    Filed: July 11, 2017
    Date of Patent: December 4, 2018
    Assignee: Ningbo Bright Max Co., Ltd.
    Inventor: Xuefeng Zhu
  • Patent number: D835820
    Type: Grant
    Filed: July 11, 2017
    Date of Patent: December 11, 2018
    Assignee: Ningbo Bright Max Co., Ltd.
    Inventor: Xuefeng Zhu